NCT01957072

Brief Summary

Cystic Fibrosis (CF) is a lifelong condition which causes the lungs and digestive system to become clogged with thick, sticky mucus. This leads to recurrent lung infections and reduced nutrients absorption from food. The average age at death is 26 years, usually from respiratory failure. Nonetheless, the nutritional status of people with CF (PWCF) is important help them live healthier and longer. It is recommended that adult with CF achieve a BMI of 23 for males and 22 for females. However, fewer than 50% adult with CF achieved that target BMI despite effective nutritional support to help support weight gain. There is a clear need for a behavioural intervention that can help PWCF use the available nutritional support. This is a feasibility study to try out a multi-component behavioural intervention. The intervention is designed to help PWCF use their nutritional support to gain weight. It will focus on testing the methods and procedures to be used on a larger scale, improving the behavioural intervention and estimating the how many people are needed for the larger trial. All eligible 75 PWCF in Sheffield will be invited to participate. The investigators anticipate recruiting 30 participants. Participants will be divided into two groups. The first group receive the behavioural intervention immediately. The second group receive the intervention after 3 months. All participants will be followed up for 6 months. Data will be collected every 6 weeks during clinic reviews. These two groups will be compared against each other to estimate the potential impact of the behavioural intervention. The investigators will also interview some of the participants at the end of the study period to improve the intervention and the study processes based on participant feedback. The investigators hypothesised that this study will recruit around 30 participants, around 80% of the participants will complete the study, a single full-time investigator can deliver the intervention to 15 participants over 3 months and data collection will be thorough (with less than 5% missing data). The investigators also hypothesised that this feasibility study will help improve the intervention and help the design of a larger trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 30, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 8, 2013

Completed
4 months until next milestone

Study Start

First participant enrolled

February 1, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

March 11, 2015

Status Verified

March 1, 2015

Enrollment Period

10 months

First QC Date

September 30, 2013

Last Update Submit

March 10, 2015

Conditions

Keywords

Cystic fibrosisNutritionWeightBMIBehaviour change

Outcome Measures

Primary Outcomes (2)

  • Proportion of patients who accepted invitation to participate as a marker of feasibility

    4 weeks

  • Proportion of people with CF who are randomised into the study after accepting the invitation to participate, as a marker of feasibility

    4 weeks

Secondary Outcomes (7)

  • Participants' opinion about the behavioural intervention

    6 months

  • Participant attrition rate and phases of study whereby the attrition occurs

    6 months

  • Participants' opinion about the study processes

    6 months

  • Participants' suggestions for further improvement of the intervention and study processes

    6 months

  • Proportion of adults who fulfils the BMI criteria for recruitment with IT facilities

    2 weeks

  • +2 more secondary outcomes

Other Outcomes (4)

  • Body mass index

    6 months

  • Weight

    6 months

  • Beliefs about Medicines Questionnaire (BMQ) score

    6 months

  • +1 more other outcomes

Study Arms (2)

Behaviour change intervention

EXPERIMENTAL

Intensive behaviour change intervention for 3 months, followed by a maintenance phase for 3 months

Behavioral: Behaviour change intervention

Wait-list Control

OTHER

Usual care for 3 months, followed by intensive behaviour change intervention for 3 months

Behavioral: Behaviour change intervention

Interventions

The behaviour change intervention consists of 1. feedback via a web-based food diary 2. 'coaching' with problem-solving and implementation plans The intensive intervention phase consists of 2 home visits, 8 telephone calls and 6 reminder emails. The maintenance phase consists of 3 telephone calls and 4 reminder emails.

Behaviour change interventionWait-list Control

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • adult people with CF looked after at the Sheffield Adult CF Unit
  • best BMI of \< 23 for males and \< 22 for females between Oct '12 and Oct '13

You may not qualify if:

  • patients in the palliative phase of disease
  • patients who are pregnant
  • patients who have no capacity to consent to participate in the study
  • patients who have no IT facilities to use the web-based food diary
  • patients who are unable to communicate by telephone for coaching

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield, South Yorkshire, S5 7AU, United Kingdom

Location

MeSH Terms

Conditions

Cystic FibrosisBody Weight

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Martin J Wildman, PhD

    Sheffield Teaching Hospitals NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 30, 2013

First Posted

October 8, 2013

Study Start

February 1, 2014

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

March 11, 2015

Record last verified: 2015-03

Locations